Imaging the accumulation and suppression of tau pathology using multiparametric MRI

Abstract Mouse models of Alzheimer's disease have served as valuable tools for investigating pathogenic mechanisms relating to neurodegeneration, including tau-mediated and neurofibrillary tangle pathology—a major hallmark of the disease. In this work, we have used multiparametric magnetic reso...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Neurobiology of aging 2016-03, Vol.39, p.184-194
Hauptverfasser: Holmes, Holly E, Colgan, Niall, Ismail, Ozama, Ma, Da, Powell, Nick M, O'Callaghan, James M, Harrison, Ian F, Johnson, Ross A, Murray, Tracey K, Ahmed, Zeshan, Heggenes, Morton, Fisher, Alice, Cardoso, M.J, Modat, Marc, Walker-Samuel, Simon, Fisher, Elizabeth M.C, Ourselin, Sebastien, O'Neill, Michael J, Wells, Jack A, Collins, Emily C, Lythgoe, Mark F
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 194
container_issue
container_start_page 184
container_title Neurobiology of aging
container_volume 39
creator Holmes, Holly E
Colgan, Niall
Ismail, Ozama
Ma, Da
Powell, Nick M
O'Callaghan, James M
Harrison, Ian F
Johnson, Ross A
Murray, Tracey K
Ahmed, Zeshan
Heggenes, Morton
Fisher, Alice
Cardoso, M.J
Modat, Marc
Walker-Samuel, Simon
Fisher, Elizabeth M.C
Ourselin, Sebastien
O'Neill, Michael J
Wells, Jack A
Collins, Emily C
Lythgoe, Mark F
description Abstract Mouse models of Alzheimer's disease have served as valuable tools for investigating pathogenic mechanisms relating to neurodegeneration, including tau-mediated and neurofibrillary tangle pathology—a major hallmark of the disease. In this work, we have used multiparametric magnetic resonance imaging (MRI) in a longitudinal study of neurodegeneration in the rTg4510 mouse model of tauopathy, a subset of which were treated with doxycycline at different time points to suppress the tau transgene. Using this paradigm, we investigated the sensitivity of multiparametric MRI to both the accumulation and suppression of pathologic tau. Tau-related atrophy was discernible from 5.5 months within the cortex and hippocampus. We observed markedly less atrophy in the treated rTg4510 mice, which was enhanced after doxycycline intervention from 3.5 months. We also observed differences in amide proton transfer, cerebral blood flow, and diffusion tensor imaging parameters in the rTg4510 mice, which were significantly less altered after doxycycline treatment. We propose that these non-invasive MRI techniques offer insight into pathologic mechanisms underpinning Alzheimer's disease that may be important when evaluating emerging therapeutics targeting one of more of these processes.
doi_str_mv 10.1016/j.neurobiolaging.2015.12.001
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4782737</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0197458015006053</els_id><sourcerecordid>1790946103</sourcerecordid><originalsourceid>FETCH-LOGICAL-c649t-5e2d046fc378b6f0515b4568db28471d68ded194e38947c58b5a85d87ea699043</originalsourceid><addsrcrecordid>eNqNkk9v1DAQxS0EokvhK6AcOHBJsBP_lVAlVLWwUhEShbPlOJNdL0kc7LjSfnsctlSUEyeP5ffeWPMbhN4QXBFM-LtDNUEKvnV-MDs37aoaE1aRusKYPEEbwpgsCVXiKdpgokRJmcRn6EWMB4yxoII_R2c1V3VDCdug2-34O6VY9lAYa9OYBrM4PxVm6oqY5jlAjOvd98ViUjGbZe8HvzsWKa6-rF_cbIIZYQnOFp-_bl-iZ70ZIry6P8_R9-urb5efypsvH7eXH25Ky6laSgZ1hynvbSNky3vMCGsp47Jra0kF6XIFHVEUGqmosEy2zEjWSQGGK4Vpc44uTrlzakfoLExLMIOegxtNOGpvnH78Mrm93vk7TYWsRSNywNv7gOB_JoiLHl20MAxmAp-iJkJhRTnBTZa-P0lt8DEG6B_aEKxXLvqgH3PRKxdNap25ZPvrv7_6YP4DIguuTwLIA7tzEHS0DiYLnQtgF91597-dLv4JsoObnDXDDzhCPPgUpgxFEx2zQd-uO7KuCGEYc8ya5hfGk75R</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1790946103</pqid></control><display><type>article</type><title>Imaging the accumulation and suppression of tau pathology using multiparametric MRI</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Holmes, Holly E ; Colgan, Niall ; Ismail, Ozama ; Ma, Da ; Powell, Nick M ; O'Callaghan, James M ; Harrison, Ian F ; Johnson, Ross A ; Murray, Tracey K ; Ahmed, Zeshan ; Heggenes, Morton ; Fisher, Alice ; Cardoso, M.J ; Modat, Marc ; Walker-Samuel, Simon ; Fisher, Elizabeth M.C ; Ourselin, Sebastien ; O'Neill, Michael J ; Wells, Jack A ; Collins, Emily C ; Lythgoe, Mark F</creator><creatorcontrib>Holmes, Holly E ; Colgan, Niall ; Ismail, Ozama ; Ma, Da ; Powell, Nick M ; O'Callaghan, James M ; Harrison, Ian F ; Johnson, Ross A ; Murray, Tracey K ; Ahmed, Zeshan ; Heggenes, Morton ; Fisher, Alice ; Cardoso, M.J ; Modat, Marc ; Walker-Samuel, Simon ; Fisher, Elizabeth M.C ; Ourselin, Sebastien ; O'Neill, Michael J ; Wells, Jack A ; Collins, Emily C ; Lythgoe, Mark F</creatorcontrib><description>Abstract Mouse models of Alzheimer's disease have served as valuable tools for investigating pathogenic mechanisms relating to neurodegeneration, including tau-mediated and neurofibrillary tangle pathology—a major hallmark of the disease. In this work, we have used multiparametric magnetic resonance imaging (MRI) in a longitudinal study of neurodegeneration in the rTg4510 mouse model of tauopathy, a subset of which were treated with doxycycline at different time points to suppress the tau transgene. Using this paradigm, we investigated the sensitivity of multiparametric MRI to both the accumulation and suppression of pathologic tau. Tau-related atrophy was discernible from 5.5 months within the cortex and hippocampus. We observed markedly less atrophy in the treated rTg4510 mice, which was enhanced after doxycycline intervention from 3.5 months. We also observed differences in amide proton transfer, cerebral blood flow, and diffusion tensor imaging parameters in the rTg4510 mice, which were significantly less altered after doxycycline treatment. We propose that these non-invasive MRI techniques offer insight into pathologic mechanisms underpinning Alzheimer's disease that may be important when evaluating emerging therapeutics targeting one of more of these processes.</description><identifier>ISSN: 0197-4580</identifier><identifier>EISSN: 1558-1497</identifier><identifier>DOI: 10.1016/j.neurobiolaging.2015.12.001</identifier><identifier>PMID: 26923415</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Alzheimer Disease - metabolism ; Alzheimer Disease - pathology ; Alzheimer's disease ; Animals ; Atrophy - genetics ; Biomarker ; Cerebral Cortex - pathology ; Disease Models, Animal ; Doxycycline - pharmacology ; Female ; Hippocampus - pathology ; Internal Medicine ; In vivo ; Longitudinal ; Longitudinal Studies ; Magnetic Resonance Imaging - methods ; Male ; Mice, Transgenic ; MRI ; Neurofibrillary Tangles - pathology ; Neurology ; Regular ; tau Proteins - genetics ; tau Proteins - metabolism ; Tauopathies - pathology ; Tauopathy ; Transgenes - drug effects</subject><ispartof>Neurobiology of aging, 2016-03, Vol.39, p.184-194</ispartof><rights>The Authors</rights><rights>2016 The Authors</rights><rights>Copyright © 2016 The Authors. Published by Elsevier Inc. All rights reserved.</rights><rights>2016 The Authors 2016</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c649t-5e2d046fc378b6f0515b4568db28471d68ded194e38947c58b5a85d87ea699043</citedby><cites>FETCH-LOGICAL-c649t-5e2d046fc378b6f0515b4568db28471d68ded194e38947c58b5a85d87ea699043</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0197458015006053$$EHTML$$P50$$Gelsevier$$Hfree_for_read</linktohtml><link.rule.ids>230,314,776,780,881,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26923415$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Holmes, Holly E</creatorcontrib><creatorcontrib>Colgan, Niall</creatorcontrib><creatorcontrib>Ismail, Ozama</creatorcontrib><creatorcontrib>Ma, Da</creatorcontrib><creatorcontrib>Powell, Nick M</creatorcontrib><creatorcontrib>O'Callaghan, James M</creatorcontrib><creatorcontrib>Harrison, Ian F</creatorcontrib><creatorcontrib>Johnson, Ross A</creatorcontrib><creatorcontrib>Murray, Tracey K</creatorcontrib><creatorcontrib>Ahmed, Zeshan</creatorcontrib><creatorcontrib>Heggenes, Morton</creatorcontrib><creatorcontrib>Fisher, Alice</creatorcontrib><creatorcontrib>Cardoso, M.J</creatorcontrib><creatorcontrib>Modat, Marc</creatorcontrib><creatorcontrib>Walker-Samuel, Simon</creatorcontrib><creatorcontrib>Fisher, Elizabeth M.C</creatorcontrib><creatorcontrib>Ourselin, Sebastien</creatorcontrib><creatorcontrib>O'Neill, Michael J</creatorcontrib><creatorcontrib>Wells, Jack A</creatorcontrib><creatorcontrib>Collins, Emily C</creatorcontrib><creatorcontrib>Lythgoe, Mark F</creatorcontrib><title>Imaging the accumulation and suppression of tau pathology using multiparametric MRI</title><title>Neurobiology of aging</title><addtitle>Neurobiol Aging</addtitle><description>Abstract Mouse models of Alzheimer's disease have served as valuable tools for investigating pathogenic mechanisms relating to neurodegeneration, including tau-mediated and neurofibrillary tangle pathology—a major hallmark of the disease. In this work, we have used multiparametric magnetic resonance imaging (MRI) in a longitudinal study of neurodegeneration in the rTg4510 mouse model of tauopathy, a subset of which were treated with doxycycline at different time points to suppress the tau transgene. Using this paradigm, we investigated the sensitivity of multiparametric MRI to both the accumulation and suppression of pathologic tau. Tau-related atrophy was discernible from 5.5 months within the cortex and hippocampus. We observed markedly less atrophy in the treated rTg4510 mice, which was enhanced after doxycycline intervention from 3.5 months. We also observed differences in amide proton transfer, cerebral blood flow, and diffusion tensor imaging parameters in the rTg4510 mice, which were significantly less altered after doxycycline treatment. We propose that these non-invasive MRI techniques offer insight into pathologic mechanisms underpinning Alzheimer's disease that may be important when evaluating emerging therapeutics targeting one of more of these processes.</description><subject>Alzheimer Disease - metabolism</subject><subject>Alzheimer Disease - pathology</subject><subject>Alzheimer's disease</subject><subject>Animals</subject><subject>Atrophy - genetics</subject><subject>Biomarker</subject><subject>Cerebral Cortex - pathology</subject><subject>Disease Models, Animal</subject><subject>Doxycycline - pharmacology</subject><subject>Female</subject><subject>Hippocampus - pathology</subject><subject>Internal Medicine</subject><subject>In vivo</subject><subject>Longitudinal</subject><subject>Longitudinal Studies</subject><subject>Magnetic Resonance Imaging - methods</subject><subject>Male</subject><subject>Mice, Transgenic</subject><subject>MRI</subject><subject>Neurofibrillary Tangles - pathology</subject><subject>Neurology</subject><subject>Regular</subject><subject>tau Proteins - genetics</subject><subject>tau Proteins - metabolism</subject><subject>Tauopathies - pathology</subject><subject>Tauopathy</subject><subject>Transgenes - drug effects</subject><issn>0197-4580</issn><issn>1558-1497</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkk9v1DAQxS0EokvhK6AcOHBJsBP_lVAlVLWwUhEShbPlOJNdL0kc7LjSfnsctlSUEyeP5ffeWPMbhN4QXBFM-LtDNUEKvnV-MDs37aoaE1aRusKYPEEbwpgsCVXiKdpgokRJmcRn6EWMB4yxoII_R2c1V3VDCdug2-34O6VY9lAYa9OYBrM4PxVm6oqY5jlAjOvd98ViUjGbZe8HvzsWKa6-rF_cbIIZYQnOFp-_bl-iZ70ZIry6P8_R9-urb5efypsvH7eXH25Ky6laSgZ1hynvbSNky3vMCGsp47Jra0kF6XIFHVEUGqmosEy2zEjWSQGGK4Vpc44uTrlzakfoLExLMIOegxtNOGpvnH78Mrm93vk7TYWsRSNywNv7gOB_JoiLHl20MAxmAp-iJkJhRTnBTZa-P0lt8DEG6B_aEKxXLvqgH3PRKxdNap25ZPvrv7_6YP4DIguuTwLIA7tzEHS0DiYLnQtgF91597-dLv4JsoObnDXDDzhCPPgUpgxFEx2zQd-uO7KuCGEYc8ya5hfGk75R</recordid><startdate>20160301</startdate><enddate>20160301</enddate><creator>Holmes, Holly E</creator><creator>Colgan, Niall</creator><creator>Ismail, Ozama</creator><creator>Ma, Da</creator><creator>Powell, Nick M</creator><creator>O'Callaghan, James M</creator><creator>Harrison, Ian F</creator><creator>Johnson, Ross A</creator><creator>Murray, Tracey K</creator><creator>Ahmed, Zeshan</creator><creator>Heggenes, Morton</creator><creator>Fisher, Alice</creator><creator>Cardoso, M.J</creator><creator>Modat, Marc</creator><creator>Walker-Samuel, Simon</creator><creator>Fisher, Elizabeth M.C</creator><creator>Ourselin, Sebastien</creator><creator>O'Neill, Michael J</creator><creator>Wells, Jack A</creator><creator>Collins, Emily C</creator><creator>Lythgoe, Mark F</creator><general>Elsevier Inc</general><general>Elsevier</general><scope>6I.</scope><scope>AAFTH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TK</scope><scope>5PM</scope></search><sort><creationdate>20160301</creationdate><title>Imaging the accumulation and suppression of tau pathology using multiparametric MRI</title><author>Holmes, Holly E ; Colgan, Niall ; Ismail, Ozama ; Ma, Da ; Powell, Nick M ; O'Callaghan, James M ; Harrison, Ian F ; Johnson, Ross A ; Murray, Tracey K ; Ahmed, Zeshan ; Heggenes, Morton ; Fisher, Alice ; Cardoso, M.J ; Modat, Marc ; Walker-Samuel, Simon ; Fisher, Elizabeth M.C ; Ourselin, Sebastien ; O'Neill, Michael J ; Wells, Jack A ; Collins, Emily C ; Lythgoe, Mark F</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c649t-5e2d046fc378b6f0515b4568db28471d68ded194e38947c58b5a85d87ea699043</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Alzheimer Disease - metabolism</topic><topic>Alzheimer Disease - pathology</topic><topic>Alzheimer's disease</topic><topic>Animals</topic><topic>Atrophy - genetics</topic><topic>Biomarker</topic><topic>Cerebral Cortex - pathology</topic><topic>Disease Models, Animal</topic><topic>Doxycycline - pharmacology</topic><topic>Female</topic><topic>Hippocampus - pathology</topic><topic>Internal Medicine</topic><topic>In vivo</topic><topic>Longitudinal</topic><topic>Longitudinal Studies</topic><topic>Magnetic Resonance Imaging - methods</topic><topic>Male</topic><topic>Mice, Transgenic</topic><topic>MRI</topic><topic>Neurofibrillary Tangles - pathology</topic><topic>Neurology</topic><topic>Regular</topic><topic>tau Proteins - genetics</topic><topic>tau Proteins - metabolism</topic><topic>Tauopathies - pathology</topic><topic>Tauopathy</topic><topic>Transgenes - drug effects</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Holmes, Holly E</creatorcontrib><creatorcontrib>Colgan, Niall</creatorcontrib><creatorcontrib>Ismail, Ozama</creatorcontrib><creatorcontrib>Ma, Da</creatorcontrib><creatorcontrib>Powell, Nick M</creatorcontrib><creatorcontrib>O'Callaghan, James M</creatorcontrib><creatorcontrib>Harrison, Ian F</creatorcontrib><creatorcontrib>Johnson, Ross A</creatorcontrib><creatorcontrib>Murray, Tracey K</creatorcontrib><creatorcontrib>Ahmed, Zeshan</creatorcontrib><creatorcontrib>Heggenes, Morton</creatorcontrib><creatorcontrib>Fisher, Alice</creatorcontrib><creatorcontrib>Cardoso, M.J</creatorcontrib><creatorcontrib>Modat, Marc</creatorcontrib><creatorcontrib>Walker-Samuel, Simon</creatorcontrib><creatorcontrib>Fisher, Elizabeth M.C</creatorcontrib><creatorcontrib>Ourselin, Sebastien</creatorcontrib><creatorcontrib>O'Neill, Michael J</creatorcontrib><creatorcontrib>Wells, Jack A</creatorcontrib><creatorcontrib>Collins, Emily C</creatorcontrib><creatorcontrib>Lythgoe, Mark F</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Neurosciences Abstracts</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Neurobiology of aging</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Holmes, Holly E</au><au>Colgan, Niall</au><au>Ismail, Ozama</au><au>Ma, Da</au><au>Powell, Nick M</au><au>O'Callaghan, James M</au><au>Harrison, Ian F</au><au>Johnson, Ross A</au><au>Murray, Tracey K</au><au>Ahmed, Zeshan</au><au>Heggenes, Morton</au><au>Fisher, Alice</au><au>Cardoso, M.J</au><au>Modat, Marc</au><au>Walker-Samuel, Simon</au><au>Fisher, Elizabeth M.C</au><au>Ourselin, Sebastien</au><au>O'Neill, Michael J</au><au>Wells, Jack A</au><au>Collins, Emily C</au><au>Lythgoe, Mark F</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Imaging the accumulation and suppression of tau pathology using multiparametric MRI</atitle><jtitle>Neurobiology of aging</jtitle><addtitle>Neurobiol Aging</addtitle><date>2016-03-01</date><risdate>2016</risdate><volume>39</volume><spage>184</spage><epage>194</epage><pages>184-194</pages><issn>0197-4580</issn><eissn>1558-1497</eissn><abstract>Abstract Mouse models of Alzheimer's disease have served as valuable tools for investigating pathogenic mechanisms relating to neurodegeneration, including tau-mediated and neurofibrillary tangle pathology—a major hallmark of the disease. In this work, we have used multiparametric magnetic resonance imaging (MRI) in a longitudinal study of neurodegeneration in the rTg4510 mouse model of tauopathy, a subset of which were treated with doxycycline at different time points to suppress the tau transgene. Using this paradigm, we investigated the sensitivity of multiparametric MRI to both the accumulation and suppression of pathologic tau. Tau-related atrophy was discernible from 5.5 months within the cortex and hippocampus. We observed markedly less atrophy in the treated rTg4510 mice, which was enhanced after doxycycline intervention from 3.5 months. We also observed differences in amide proton transfer, cerebral blood flow, and diffusion tensor imaging parameters in the rTg4510 mice, which were significantly less altered after doxycycline treatment. We propose that these non-invasive MRI techniques offer insight into pathologic mechanisms underpinning Alzheimer's disease that may be important when evaluating emerging therapeutics targeting one of more of these processes.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>26923415</pmid><doi>10.1016/j.neurobiolaging.2015.12.001</doi><tpages>11</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0197-4580
ispartof Neurobiology of aging, 2016-03, Vol.39, p.184-194
issn 0197-4580
1558-1497
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4782737
source MEDLINE; Elsevier ScienceDirect Journals
subjects Alzheimer Disease - metabolism
Alzheimer Disease - pathology
Alzheimer's disease
Animals
Atrophy - genetics
Biomarker
Cerebral Cortex - pathology
Disease Models, Animal
Doxycycline - pharmacology
Female
Hippocampus - pathology
Internal Medicine
In vivo
Longitudinal
Longitudinal Studies
Magnetic Resonance Imaging - methods
Male
Mice, Transgenic
MRI
Neurofibrillary Tangles - pathology
Neurology
Regular
tau Proteins - genetics
tau Proteins - metabolism
Tauopathies - pathology
Tauopathy
Transgenes - drug effects
title Imaging the accumulation and suppression of tau pathology using multiparametric MRI
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-31T12%3A15%3A14IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Imaging%20the%20accumulation%20and%20suppression%20of%20tau%20pathology%20using%20multiparametric%20MRI&rft.jtitle=Neurobiology%20of%20aging&rft.au=Holmes,%20Holly%20E&rft.date=2016-03-01&rft.volume=39&rft.spage=184&rft.epage=194&rft.pages=184-194&rft.issn=0197-4580&rft.eissn=1558-1497&rft_id=info:doi/10.1016/j.neurobiolaging.2015.12.001&rft_dat=%3Cproquest_pubme%3E1790946103%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1790946103&rft_id=info:pmid/26923415&rft_els_id=S0197458015006053&rfr_iscdi=true